The COVID-19 vaccine approvals have given health systems (and payers) a glimmer of hope that the surge of acute patient COVID-19 admissions may be ebbing. As we anticipate a sense of normalcy, the shift for payer organizations will likely be toward planning our 2021 healthcare strategies.
Despite so many unknowns, now is the time for providers to take stock of their health system’s financial position and make proactive decisions around setting service rates, negotiating contracts, and mapping potential expansion opportunities. A good first step? Accessing comprehensive data on medical reimbursements.
As COVID-19 and social distancing concerns continue to impact healthcare delivery across the country, telehealth technology has emerged as the number one way to deliver care. Through remote patient evaluation, diagnosis, and treatment via telecommunication systems, providers deliver vital clinical services to patients – reducing care gaps and preventing exposure to the virus.
Healthcare companies are making big investments into these new platforms, but have these organizations made the same investment into fueling that platform with the best data?